Krsnaa Diagnostics' Q4 FY 2025-26 Quarterly Results

Result Summary

• Krsnaa Diagnostics Ltd reported a 21.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 17.7%.
• Its expenses for the quarter were up by 4.4% QoQ and 6.5% YoY.
• The net profit increased 173.6% QoQ and increased 101.7% YoY.
• The earnings per share (EPS) of Krsnaa Diagnostics Ltd stood at 12.7 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Krsnaa Diagnostics Ltd is a company that operates within the healthcare sector, specifically focusing on providing diagnostic services. As a key player in the diagnostics industry, Krsnaa Diagnostics offers a range of medical testing services, which include imaging, pathology, and radiology services, among others. The company is known for its extensive network of diagnostic centers across various regions, catering to both urban and rural populations. Krsnaa Diagnostics aims to provide high-quality and affordable diagnostic solutions, contributing to enhanced healthcare access. Any recent major developments or strategic initiatives that the company might have undertaken are not available within the provided data.

Revenue

In Q4FY26, Krsnaa Diagnostics Ltd reported a total income of ₹224.10 crores, marking a significant increase of 21.2% compared to the previous quarter, Q3FY26, which recorded ₹184.97 crores. This growth is also reflected year-over-year, with a 17.7% increase from ₹190.46 crores in Q4FY25. The consistent rise in total income over these periods indicates robust revenue generation, which could be attributed to various factors such as increased service uptake, expansion of service offerings, or enhanced operational capabilities. However, specific drivers of this revenue growth are not detailed within the data provided.

Profitability

Krsnaa Diagnostics Ltd's profitability metrics for Q4FY26 demonstrate notable improvements. The profit before tax for the quarter was ₹51.71 crores, which is a substantial increase of 161.6% quarter-over-quarter from ₹19.77 crores in Q3FY26, and an 80.8% rise year-over-year from ₹28.60 crores in Q4FY25. This positive trend extends to the profit after tax, which stood at ₹41.72 crores in Q4FY26. This represents a 173.6% increase from the previous quarter and a 101.7% increase from the same quarter in the previous year. The earnings per share also reflected this growth, amounting to ₹12.70, up from ₹4.66 in Q3FY26 and ₹6.28 in Q4FY25. These figures suggest a strong performance in terms of profitability during the reported quarter.

Operating Metrics

The operating metrics for Krsnaa Diagnostics Ltd in Q4FY26 show an increase in total expenses, which reached ₹172.40 crores, up by 4.4% from ₹165.21 crores in Q3FY26 and a 6.5% increase from ₹161.86 crores in Q4FY25. Despite the rise in expenses, the company's profit before and after tax indicates effective management of operational costs relative to revenue growth. The tax expense for Q4FY26 was ₹9.98 crores, reflecting an increase of 124.8% from ₹4.44 crores in Q3FY26 and 25.9% from ₹7.93 crores in Q4FY25. These metrics provide insight into the company's operational efficiency and tax strategy within the reported period. However, specific details on strategic adjustments or operational changes contributing to these figures are not included in the provided data.